A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors


Yazici Y., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES, cilt.66, sa.1, ss.124-127, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66 Sayı: 1
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1136/ard.2006.055848
  • Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.124-127
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Background: The adequacy of reporting the time element in adverse effects in articles on randomised clinical trials of cyclooxygenase-2 and tumour necrosis factor (TNF) a antagonists was surveyed.